Telehealth General Psychiatry Prescribing: What Prescribers Can Do

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe medications through telehealth—or trying to navigate the maze of state-by-state rules and DEA requirements—you’re not alone. Teleprescribing has become essential to modern psychiatric care, but the regulatory landscape remains confusing and constantly evolving.

Here’s what you need to know to practice confidently and compliantly in 2026.

Yes, Psychiatrists Can Prescribe Medications via Telehealth—With Some Important Caveats

The short answer: Yes, psychiatrists can prescribe most psychiatric medications through telehealth nationwide, including controlled substances like stimulants (Adderall, Ritalin) and benzodiazepines (Xanax, Klonopin). This flexibility has been enabled by federal emergency waivers that remain in effect through December 31, 2025, and many expect these allowances to continue or become permanent with modifications.

However, the devil is in the details. Your ability to prescribe via telehealth depends on:

1. Federal DEA rules governing controlled substances
2. State-specific telehealth and prescribing laws where your patient is located
3. Your provider type (MD/DO vs. PMHNP) and state scope-of-practice rules
4. Proper documentation and patient relationship requirements

Let’s break down each of these.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Rules: The DEA’s Telehealth Controlled Substance Flexibility

Under the Ryan Haight Act (2008), prescribing controlled substances typically requires at least one in-person medical evaluation. But since March 2020, the DEA has temporarily waived this requirement during the COVID-19 public health emergency, and that waiver has been repeatedly extended—currently through December 31, 2025.

What this means for you right now:

• You can initiate controlled substance prescriptions for new patients via audio-visual telehealth without ever seeing them in person
• This includes Schedule II stimulants for ADHD, Schedule IV benzodiazepines for anxiety, and buprenorphine for opioid use disorder
• You must conduct a legitimate medical evaluation via secure, real-time video (audio-only typically doesn’t qualify for initial controlled substance prescriptions, though some states allow it for established patients)
• You must comply with all other DEA requirements: valid DEA registration, appropriate prescribing standards, state law compliance, and prescription monitoring program (PMP) checks

What’s coming: The DEA has proposed permanent rules that would likely require some in-person component—possibly an initial in-person visit, or at minimum a 30-day prescription limit for purely telehealth-initiated patients, with exceptions for referrals from in-person clinicians. The final rule has been delayed multiple times. Most experts expect the current flexibility to continue in some modified form given the massive adoption of telepsychiatry and access benefits, but providers should stay alert for DEA announcements in late 2024 and 2025.

Bottom line: As of February 2026, you can prescribe controlled substances via telehealth to new patients. Build your practice around this, but have a contingency plan if regulations tighten (such as requiring patients to see a local provider for an initial visit or periodic check-ins).

State-Specific Telehealth Prescribing Rules: Where It Gets Complicated

Federal law sets the floor, but states can impose additional restrictions. Every state has its own telehealth laws, and some have carved out specific allowances or prohibitions for prescribing controlled substances remotely. Here’s how the major states relevant to psychiatric practice break down:

Florida: Psychiatric Treatment Explicitly Permitted

Florida is one of the most permissive states for tele-prescribing psychiatric medications. Florida Statutes (456.47) explicitly allow controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders—a carve-out that doesn’t exist for most other conditions.

• Florida psychiatrists can initiate ADHD medications, anti-anxiety controlled substances, and other psychotropics via video visit without an in-person exam
• The only major prohibition is for chronic pain management (long-term opioid therapy), which still requires an in-person visit
• Florida’s law recognizes audio-visual telemedicine as establishing a valid patient-physician relationship for prescribing purposes

For PMHNPs in Florida: The state is more restrictive. Psychiatric nurse practitioners must practice under a supervising physician’s protocol and can only prescribe psychotropic controlled substances if they meet Florida’s definition of a ‘psychiatric nurse’ (PMHNP with ≥2 years experience under a psychiatrist) and have explicit delegation in their collaborative agreement. Even with that, they remain under physician oversight—Florida did not include psychiatric NPs in its 2020 ‘autonomous APRN’ law, which only granted independence to primary care NPs.

Texas: Mental Health Treatment Allowed, Pain Management Restricted

Texas permits telehealth prescribing for mental health but bans it for chronic pain. Under Texas Medical Board rules, psychiatrists can prescribe controlled substances via telemedicine if the encounter meets the standard of care (typically requiring real-time audio-visual interaction).

• Texas law specifically prohibits prescribing Schedule II opioids for chronic pain management via telehealth—you must see these patients in person
• For psychiatric conditions (ADHD, anxiety, etc.), there is no such prohibition—stimulants and benzodiazepines can be prescribed via telehealth under federal allowances
• Texas requires checking the Prescription Monitoring Program (PMP) before prescribing any controlled substance, telehealth or in-person

For PMHNPs in Texas: Texas is one of the most restrictive states for nurse practitioners. PMHNPs cannot practice or prescribe independently—they must have a Prescriptive Authority Agreement with a Texas-licensed physician. Even with delegation, Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (with very limited exceptions like hospice care or certain pediatric ADHD protocols). In practice, most Texas telepsychiatry platforms pair psychiatrists for stimulant prescribing with NPs handling non-controlled medications or therapy.

New York: State Rules Now Align with Federal Flexibility

New York recently updated its regulations to eliminate state-level conflicts with federal telehealth allowances. In mid-2025, the New York State Department of Health finalized rules that permit controlled substance prescribing via telehealth when consistent with federal DEA waivers.

• Previously, NY technically required an in-person exam for controlled substances (this was suspended under emergency orders during COVID)
• The new rule codifies exceptions: providers can prescribe controlled substances via telehealth if federal law allows it, or if another practitioner performed an in-person exam within 12 months, or for short-term emergency prescriptions
• Psychiatrists can confidently initiate ADHD medications, buprenorphine, and other controlled psychiatric meds via video visit under current rules

For PMHNPs in New York: New York has one of the better systems for psychiatric NPs. After completing 3,600 hours of supervised practice (roughly 2 years full-time), PMHNPs can practice independently without ongoing physician oversight—they only need an attestation of having informal ‘collaborative relationships’ with physicians for referrals. This means experienced NY PMHNPs can prescribe controlled substances on their own just like psychiatrists.

California: Transitioning to NP Independence, Telehealth-Friendly

California allows telehealth prescribing as long as the ‘good faith examination’ requirement is met—and a telehealth video exam qualifies. There’s no state law prohibiting controlled substance prescribing via telehealth; California defers to federal DEA rules.

• Psychiatrists have full prescribing authority via telehealth in California
• Must check CURES (California’s prescription monitoring database) before prescribing Schedule II–IV medications (at least once every 4 months for ongoing therapy)
• California has strong telehealth parity laws—private insurers must cover and generally reimburse telehealth at the same rates as in-person

For PMHNPs in California: California is in transition. Under AB 890 (2020), experienced NPs (≥3 years) can practice with increasing autonomy. As of 2023, they can work in group settings without direct physician supervision (‘103 NP’ certification). Starting January 1, 2026, those experienced NPs can apply for full independent practice authority (‘104 NP’), including prescribing. New graduate NPs still need to work under physician-approved standardized procedures for their first 3 years. By 2026, California will effectively be a full-practice state for seasoned PMHNPs.

Pennsylvania: Collaboration Required, Telehealth Permitted

Pennsylvania has no specific telehealth prescribing prohibitions beyond federal law, but PMHNPs face practice restrictions.

• Psychiatrists can prescribe via telehealth without additional state barriers
• Pennsylvania requires NPs to maintain a collaborative agreement with a physician for their entire career (no independent practice pathway yet, though legislation has been proposed)
• The collaborating physician must review NP charts periodically; for Schedule II prescriptions by NPs, the physician must be notified within 24 hours and often must countersign

For PMHNPs in Pennsylvania: You’ll need a collaborating psychiatrist or physician to prescribe. The collaborative agreement must detail your prescriptive authority. While this adds administrative burden, Pennsylvania Medicaid and commercial payers do cover telepsychiatry at parity, making the practice economically viable.

Illinois: Path to Independence After Experience

Illinois allows telehealth prescribing consistent with federal rules, and has implemented a graduated autonomy system for NPs.

• PMHNPs must initially practice under a Written Collaborative Agreement with a physician
• After completing 4,000 hours of supervised practice (about 2 years) plus 250 hours of continuing education, NPs can apply for Full Practice Authority from the Illinois nursing board
• Once granted FPA, PMHNPs can prescribe independently, including controlled substances (they must obtain their own mid-level controlled substance registration)
• Illinois has strong telehealth parity—SB 667 (2021) mandates equal reimbursement for telehealth through at least 2027

Bottom line on state rules: Always verify the current telehealth and prescribing laws in the state where your patient is located at the time of service. You must be licensed in that state, and you must follow both federal and state rules. When in doubt, check your state medical board website or the Center for Connected Health Policy for up-to-date telehealth regulations.

Establishing a Valid Patient Relationship via Telehealth

Every state requires a legitimate patient-provider relationship before prescribing. The good news: virtually all states now recognize audio-visual telemedicine as establishing that relationship, as long as it meets the same standard of care as an in-person visit.

What constitutes a valid telehealth encounter for prescribing:

• Real-time, two-way audio-visual communication (video visit via secure HIPAA-compliant platform)
• Thorough clinical evaluation: taking a complete history, mental status examination, reviewing prior records when available, discussing risks/benefits of medications
• Informed consent: documenting that the patient understands the limitations of telehealth and consents to treatment via this modality (some states like Texas and California explicitly require this)
• Identity verification: confirming you’re speaking to the right patient
• Documentation: charting with the same detail as an in-person visit, noting the technology used and the patient’s location

Audio-only (telephone) visits: Some states and payers have started allowing audio-only visits for mental health follow-ups, especially to address access barriers. Medicare, for example, temporarily reimburses certain mental health services delivered via telephone (for patients who can’t access video) through at least 2024. However, for initial controlled substance prescriptions, federal and most state laws require video—audio alone typically won’t satisfy the ‘in-person or equivalent’ exam requirement. Once a patient is established, brief phone check-ins for medication adjustments may be permissible depending on state law and payer policy.

PMHNP vs. Psychiatrist: How Prescribing Authority Differs

Understanding the scope-of-practice differences is critical, especially if you’re building a telehealth team or deciding where to practice.

Psychiatrists (MD/DO):

• Full independent prescribing authority in all 50 states
• No collaborative agreement or supervision required
• Can prescribe any psychiatric medication, including all controlled substances, immediately upon licensure
• Only limitations are specialty-specific (e.g., need X-waiver training for buprenorphine previously, though that requirement was eliminated in 2023; REMS enrollment for clozapine, etc.)

Psychiatric Mental Health NPs (PMHNPs):

Authority varies dramatically by state, falling into three categories:

1. Full Practice Authority States (~34 states): PMHNPs can practice and prescribe independently without physician oversight. Examples include Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, Massachusetts, Rhode Island, Connecticut, Maryland, and many others. In these states, an experienced PMHNP has essentially the same prescribing authority as a psychiatrist (they operate under nursing board rules but can diagnose, treat, and prescribe controlled substances under their own DEA registration).

2. Reduced Practice / Transition-to-Independence States: PMHNPs start with required physician collaboration but can earn independence after meeting experience thresholds.

• New York: 3,600 hours supervised → independent practice
• Illinois: 4,000 hours + 250 CE hours → Full Practice Authority
• California: 3 years experience → increasing autonomy (full independence available 2026)

3. Restricted Practice States: PMHNPs require ongoing physician supervision/collaboration indefinitely.

• Texas: Must have Prescriptive Authority Agreement; cannot prescribe Schedule II in most outpatient settings
• Florida: Must practice under physician protocol; ‘psychiatric nurse’ designation allows more autonomy for psychotropics but still requires psychiatrist collaboration
• Pennsylvania: Must maintain collaborative agreement for entire career; physician must review charts and approve prescriptive authority

Reimbursement differences: Even where NPs have full prescribing authority, Medicare pays NPs at 85% of the physician fee schedule. Many private insurers follow similar policies. Some states (Nevada, Maryland) have passed equal pay laws, but in most places, a psychiatric practice generates slightly less revenue per visit if seen by an NP vs. an MD—something to factor into practice economics.

Practical implication: If you’re a psychiatrist practicing telehealth, you can see patients in any state where you’re licensed without needing to find a collaborator. If you’re a PMHNP, you need to research each state’s requirements—you may need to secure a collaborating psychiatrist in restricted states, which can delay your ability to practice and may incur monthly collaboration fees (typically $500–$2,000/month).

Reimbursement for Medication Management via Telehealth

One of the biggest questions providers have: Will I get paid the same for telehealth as in-person?

For psychiatric medication management, the answer is increasingly yes—at least for mental health services.

Medicare Reimbursement (2026 Rates)

Medicare has extended telehealth coverage for mental health services and generally pays the same for telehealth as office visits:

• Initial psychiatric evaluation (90792): ~$173
• 15-minute med check follow-up (99213): ~$92–96
• 25-minute med check follow-up (99214): ~$125–136
• Psychotherapy add-on codes (if doing therapy + meds in same visit): +$80 (for 30-min add-on) to $135 (for 60-min add-on)

Important Medicare requirement: Starting in 2025, Medicare beneficiaries receiving tele-mental health services must have an in-person visit with any provider at least once every 12 months (this requirement has been repeatedly delayed but is expected to take effect soon). This doesn’t have to be with you specifically—it can be with their PCP or any other provider—but it’s worth informing patients.

NPs get 85% of these rates when billing under their own NPI for Medicare patients.

Private Insurance Reimbursement

Commercial insurance rates vary by region and contract, but typically pay more than Medicare:

• A major insurer might pay $150 for a 99213 and $200 for a 99214 in high-cost areas
• Telehealth parity laws in over 40 states require insurers to cover telehealth services, and many mandate payment parity for behavioral health
• States with strong parity: California (AB 744), Illinois (SB 667 through 2027), New York (2021 updates), Connecticut, Massachusetts

Texas does not mandate payment parity, but in practice most insurers voluntarily pay equal rates for tele-mental health given high demand.

Medicaid

Medicaid rates are typically lower than Medicare (often $60–80 for a med check in states like Florida), but many state Medicaids have enhanced telehealth coverage:

• New York Medicaid: pays same rate for telehealth as in-person for mental health
• Pennsylvania Medicaid: permanent telehealth coverage with parity
• California Medi-Cal: historically paid ~75% of Medicare rates; recent investments aimed to raise behavioral health reimbursement

Cash-Pay / Self-Pay Models

Many psychiatrists, especially in high-demand areas like ADHD treatment, practice on a cash-pay basis:

• Typical cash rates: $200–300 for initial evaluation, $100–200 for 15–20 minute follow-ups
• No insurance billing overhead
• Patients may submit superbills for out-of-network reimbursement

The economics work if you maintain high utilization—but you’re limiting your patient pool to those who can afford to pay out-of-pocket.

How Klarity Health Makes Teleprescribing Economically Smart

Here’s where the traditional practice-building model breaks down for most psychiatrists and PMHNPs: patient acquisition is expensive and time-consuming.

Reality check on DIY marketing costs:

If you’re trying to build your own telehealth practice, here’s what acquiring a new psychiatric patient actually costs:

• SEO: 6–12 months of consistent investment ($2,000–5,000/month for agencies) before you see meaningful patient flow
• Google Ads: Mental health keywords cost $15–40+ per click; most clicks don’t convert. Realistic cost per booked patient: $200–400+ when you factor in testing, optimization, and no-shows from cold leads
• Psychology Today directory: Monthly listing fees plus competing with hundreds of other providers on the same page
• Zocdoc: $35–100+ per patient booking, plus monthly subscription fees (easily $500–1,000+/month)
• Staff time: Someone has to field inquiries, qualify leads, schedule appointments, follow up on no-shows
• Failed experiments: Most solo providers waste $3,000–5,000 testing channels that don’t work before finding what does

Total realistic monthly marketing spend for a solo provider: $3,000–5,000+, with uncertain results and a 6–12 month ramp before you’re fully booked.

Klarity Health’s model removes that entire risk:

Instead of gambling thousands on marketing channels, you pay only when a qualified patient books with you—a standard per-appointment listing fee for new patient leads. No upfront spend. No monthly subscriptions. No wasted ad dollars.

What you get:

• Pre-qualified patients already matched to your specialty, availability, and insurance acceptance
• Both insurance and cash-pay patient flow (you decide your panel mix)
• Built-in telehealth infrastructure—no need to pay separately for a platform like Doxy.me or SimplePractice (which run $30–100/month each)
• You control your schedule—you only pay when you see patients

The economic case: Instead of spending $4,000/month on marketing with uncertain ROI, you pay a predictable fee per patient you actually see. If a new patient generates $500–1,000+ in lifetime value (initial eval + follow-ups), and you’re paying a one-time listing fee that’s a fraction of that, the math works—guaranteed ROI vs. gambling on marketing.

For providers just starting out or scaling up, this removes the biggest barrier: how do I get patients without breaking the bank?

Compliance Checklist: Prescribing via Telehealth Safely and Legally

To practice confidently, make sure you’re checking these boxes:

Licensing & Registration:

• ☑ Hold active medical/nursing license in the state where the patient is physically located during the visit
• ☑ Have valid DEA registration (for controlled substances)
• ☑ If seeing patients across multiple states, obtain licenses in each state (consider IMLC for expedited licensure in member states: PA, IL, TX are members; NY, CA, FL are not)

Technology & Documentation:

• ☑ Use HIPAA-compliant telehealth platform
• ☑ Obtain informed consent for telehealth (document patient understands risks/limitations)
• ☑ Verify patient identity and location at start of each encounter
• ☑ Document visit with same detail as in-person: chief complaint, history, mental status exam, assessment, plan, time spent, and note that visit was conducted via telehealth
• ☑ Have emergency protocol in place (what to do if patient is in crisis and disconnects)

Prescribing:

• ☑ Check state Prescription Monitoring Program (PMP) before prescribing controlled substances (required in TX, NY, CA, FL, PA, IL and most other states)
• ☑ Use e-prescribing for controlled substances where required (New York mandates e-prescribing; paper scripts not allowed)
• ☑ Follow quantity and duration limits (e.g., some states limit initial Schedule II prescriptions to 30 days)
• ☑ Document rationale for controlled substance prescription, risks discussed, and PMP review

State-Specific:

• ☑ For restricted NP states: ensure collaborative agreement is current and filed with state board
• ☑ For states with specific telehealth rules: follow consent documentation requirements, check whether audio-only is permitted for your service type
• ☑ Stay updated on DEA rule changes (subscribe to DEA updates or professional association newsletters)

FAQ: Common Teleprescribing Questions

Q: Can I prescribe Adderall or Ritalin to a new patient I’ve never met in person?

A: Yes, as of February 2026, under current DEA flexibilities. You must conduct a thorough video evaluation and follow all prescribing standards, including checking your state’s PMP. Be prepared for potential rule changes that could require some in-person component in the future.

Q: What if my patient doesn’t have video capability—can I prescribe over the phone?

A: For established patients and non-controlled medications, some states and payers allow audio-only follow-ups. For initial controlled substance prescriptions, federal and most state rules require video. Check your state’s specific telehealth laws and your payer contracts.

Q: Do I need a separate DEA registration for each state I prescribe in via telehealth?

A: No. You need only one DEA registration (typically in your primary state of practice). However, you must be licensed in each state where your patients are located, and some states require you to report your DEA number to their state licensing board or controlled substance authority.

Q: How do reimbursement rates compare for telehealth vs. in-person in psychiatry?

A: In most states with telehealth parity laws, rates are identical for behavioral health services. Medicare pays the same for telehealth mental health visits as office visits. Some private insurers in states without parity laws may pay slightly less, but the trend is toward equal payment.

Q: As a PMHNP, can I prescribe the same medications as a psychiatrist?

A: It depends on your state. In Full Practice Authority states (and reduced-practice states after you meet experience requirements), yes—you can prescribe all psychiatric medications including controlled substances under your own authority. In restricted states like Texas or Florida, your prescribing authority is limited by your collaborative agreement and state formulary restrictions (e.g., Texas NPs generally cannot prescribe Schedule II stimulants in outpatient settings).

Q: What happens if the DEA finalizes stricter telehealth rules?

A: Most expect some form of continued flexibility given the widespread adoption and access benefits of telepsychiatry. Likely scenarios include: requiring an in-person visit within the first 6–12 months of treatment, allowing 30-day prescriptions via telehealth before requiring in-person, or exempting patients referred by another provider who did an in-person exam. Stay informed through professional associations (APA, AAPP, AANP) and adjust your practice model as needed—for example, partnering with local clinics for initial visits or periodic check-ins.

The Bottom Line: Telehealth Prescribing is Here to Stay—Practice Smartly

Psychiatrists and psychiatric nurse practitioners can confidently prescribe medications via telehealth in 2026, including controlled substances for conditions like ADHD, anxiety, and depression. The regulatory environment has stabilized enough that you can build a sustainable practice around telepsychiatry, though you must navigate state-by-state variations carefully.

Key takeaways:

1. Federal law currently permits controlled substance prescribing via telehealth without an in-person visit (through Dec 2025, likely to continue with modifications)

2. State laws vary significantly—some states (FL, CA, NY, IL) are quite permissive; others (TX) have more restrictions. Always check the rules in your patient’s state.

3. Provider type matters—psychiatrists have universal authority; PMHNPs must navigate state scope-of-practice laws that range from full independence to required supervision

4. Reimbursement is strong—telehealth parity for mental health means you’ll be paid fairly, especially by Medicare and in states with parity laws

5. Patient acquisition is the real challenge—building your own practice through traditional marketing costs $3,000–5,000+/month with uncertain results

Platforms like Klarity Health solve the patient acquisition problem by delivering pre-qualified patients to your virtual door, eliminating upfront marketing costs and letting you focus on what you do best: providing excellent psychiatric care. You only pay when you see patients, turning patient acquisition from a financial gamble into a predictable, scalable cost structure.

Whether you’re an established psychiatrist looking to expand into telehealth or a PMHNP starting your career, understanding these prescribing rules—and having a smart patient acquisition strategy—is essential to building a thriving, compliant telepsychiatry practice.

Ready to see patients without the marketing headaches? Explore how Klarity Health’s provider network gives you access to a steady patient flow, built-in telehealth tools, and the freedom to practice on your terms—learn more about joining Klarity’s provider platform.

Sources and References

1. California Board of Registered Nursing – AB 890 Implementation FAQs (www.rn.ca.gov/practice/ab890.shtml) – Updated Nov 2023
2. Texas Board of Nursing – APRN Practice FAQ (www.bon.texas.gov/faqpracticeaprn.asp.html) – Revised 2021
3. Zivian Health ‘2026 NP-Physician Collaboration Regulations Roadmap’ (www.zivianhealth.com/blog/np-physician-collaboration-regulations-your-compliance-roadmap) – Feb 16, 2026
4. NursePractitionerLicense.com – Illinois NP Practice Limitations (www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois) – Updated Feb 12, 2024
5. JDSupra Law News – ‘New Law Allows Experienced NPs to Practice Without Collaborative Relationship’ (www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796) – April 13, 2022
6. Florida Statutes Chapter 464.012 & 456.47 (www.flsenate.gov/laws/statutes/2024/464.012) – 2024 Statute Compilation
7. Pennsylvania Coalition of Nurse Practitioners – Scope of Practice (www.pacnp.org/general/custom.asp?page=ScopeofPractice) – Updated 2022
8. NursePractitionerOnline.com – ‘Nurse Practitioner Practice Authority Updates 2026’ (www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates) – Last verified Feb 5, 2026
9. Center for Connected Health Policy – Texas Telehealth Laws (www.cchpca.org/texas) – Updated Jan 19, 2026
10. National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates’ (natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era) – Aug 15, 2025
11. Nixon Peabody Client Alert – ‘New York State Finalizes Telemedicine Rule for Controlled Substances’ (www.nixonpeabody.com/insights/alerts/2025/06/18/new-york-state-finalizes-telemedicine-rule-for-controlled-substances) – June 18, 2025
12. Texas Nurse Practitioners Association – DEA Telehealth Extension News (texasnp.org/news-laws-and-regulations) – Oct 6, 2023
13. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026 Update]’ (therathink.com/insurance-reimbursement-rates-for-psychiatrists) – 2026 Edition
14. Healing Psychiatry Florida – ‘Psychiatrist Shortage by State’ (www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state) – Jan 15, 2026
15. Texas Capitol – SB 406 Bill Analysis (capitol.texas.gov/tlodocs/83R/analysis/html/SB00406I.htm) – 83rd Legislature, 2013

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship